Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although NAM has been shown to be effective to increase NAD+ in tissues, it also exerts an inhibitory effect on sirtuin [88] and PARPs activity [89].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [88]
In the citing paper
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [64]
Citations
Cites
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Extrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Self-citationPosition effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990) · Cell · doi:10.1016/0092-8674(90)90141-z · Cited by 1,345
Research works printed but not linked: 1
- Gasser, 1998, Novartis Found. Symp., 214, 114
Cited by
Items 801–900 of 1,000
Hong, S., Lee, H.-G., & Huh, W. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107273 · Cited by 5
“The enzymatic activity of Sir2 and its association with rDNA are upregulated by nicotinamidase Pnc1, which converts nicotinamide, a physiological inhibitor of Sir2, to nicotinic acid (9).”
The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia—A Promising Road Ahead
Strzałka, P., Krawiec, K. M., Wiśnik, A., Jarych, D., Czemerska, M., Zawlik, I., Pluta, A., & Wierzbowska, A. (2025) · Cancers · doi:10.3390/cancers17061009 · Cited by 5
Liu, P., Zhang, J., Zhang, J., Yuan, Y., Liu, Z., Chen, S., Chen, K., Li, D., Cheng, Z., Zhang, Y., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1566567 · Cited by 5
Wegner, C., Kim, B., & Lee, J. (2013) · Nutrients · doi:10.3390/nu5010208 · Cited by 5
“Interestingly, nicotinamide, a product of SIRT deacetylation reactions, is a known feedback inhibitor of SIRT activity [89].”
BackgroundAldrovani, M., Sobrinho, A. A. F. B., Mairos, F. S., & Laus, J. L. (2017) · Cornea · doi:10.1097/ico.0000000000001221 · Cited by 5
Saad, F. A. (2024) · Current Gene Therapy · doi:10.2174/0115665232286489240320051925 · Cited by 6
Dykes, S. S., Friday, E., Pruitt, K., & Cardelli, J. A. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.07.015 · Cited by 7
Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease
Polito, L., Biella, G., & Albani, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00008-9 · Cited by 7
Wang, Y., Ryu, H. S., & Jang, J. J. (2018) · Molecular & Cellular Toxicology · doi:10.1007/s13273-018-0006-4 · Cited by 6
Li, Y., Zhao, Y., Cao, Z., Wang, J., Liu, T., Li, Y., Wang, Y., & He, B. (2021) · RSC Advances · doi:10.1039/d0ra09424b · Cited by 6
Enhancing NAD+ Metabolome in Cardiovascular Diseases: Promises and Considerations
Jahan, F., & Bagchi, R. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.716989 · Cited by 5
Gong, S., Hu, G., Guo, R., Zhang, J., Yang, Y., Ji, B., Li, G., & Yao, H. (2022) · Cell Regeneration · doi:10.1186/s13619-022-00131-w · Cited by 5
Nguyen‐Khuong, T., White, M. Y., Hung, T., Seeto, S., THOMAS, M. L., Fitzgerald, A. M., Martucci, C. E., Luk, S., Pang, S., Russell, P. J., et al. (2009) · PROTEOMICS · doi:10.1002/pmic.200700839 · Cited by 5
Coppedè, F., Bosco, P., Fuso, A., & Troen, A. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/926082 · Cited by 9
NAD+ Homeostasis and Autophagy: Integrated Control Through Nutrient Signaling in Yeast and Mammals
McDaniel, M., Lee, L.-H., & Lin, S.-J. (2025) · Cells · doi:10.3390/cells14191495 · Cited by 4
“Therefore, NAM supplementation is associated with a loss of Sir2-mediated silencing and a decrease in RLS [231].”
Histone deacetylase 6 inhibits STING-dependent antiviral immunity via site-specific deacetylation
Qu, M., Wei, D., Ke, Q., Cheng, P., Ma, Y., Afera, B., Guo, K., Li, M., Yin, X., Wang, X., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110841 · Cited by 4
Inoue, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802005-0.00043-4 · Cited by 4
Short-term effects induced by nicotinamide in ovariectomized females
Lima, N. C. G. C., de Souza, S. A. R., Vieira, B. D. S., Rizzi, J. S., de Andrade, T. A. M., de Oliveira, C. A., & do Amaral, M. E. C. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0195 · Cited by 4
Hawrylyshyn, K., Yin, H. R., O’Neil, C. H., Watson, A., & Pickering, J. G. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.07.477 · Cited by 5
“The limitation of NMN is an additional step for uptake; NA results in flushing side effect (229, 230), and Nam inhibits SIRT activity (231).”
BackgroundStructural Biology of Epigenetic Targets
Romier, C., Wurtz, J., Renaud, J., & Cavarelli, J. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627073.ch2 · Cited by 4
Sirtuin Activation by Small Molecules
Massudi, H., Wu, L. E., & Sinclair, D. A. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_12 · Cited by 4
Self-citationMitochondrial Regulation by Protein Acetylation
Lombard, D. B., Tishkoff, D. X., & Zwaans, B. M. M. (2012) · Oxidative stress and disease · doi:10.1201/b12308-17 · Cited by 3
Cabrera, M., Eastman, B., Ennerfelt, H. E., Alsaadi, A. I., Alexandrova, L. А., Ay, Y. A., Huang, J., Wang, Q., Blacher, E., McReynolds, M. R., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03638-6 · Cited by 4
“…also observed improved outcome with a single post-ischemic dose of Nam, however, it is important to note that several other studies have demonstrated Nam inhibition of sirtu-ins, essential mediators of metabolic homeostasis, as well as the adverse effects of Nam on liver function [51, 52, 56].”
Linking the microbiome to the complement system in geographic atrophy
Spörri, L. A., Studer, J. M., Kreuzer, M., Rotzetter, J., Schärer, D., Largiadèr, C. R., Jaggi, D., Zinkernagel, M. S., & Zysset‐Burri, D. C. (2026) · npj Genomic Medicine · doi:10.1038/s41525-026-00550-7 · Cited by 5
Harnessing Genetics to Extend Lifespan and Healthspan: Current Progress and Future Directions
Ankrah, P. K., Mensah, E. D., Dabie, K., Mensah, C., Akangbe, B. O., & Essuman, J. (2024) · Cureus · doi:10.7759/cureus.55495 · Cited by 5
“Invariably, no observable increments in lifespan are noticed in Sir2 null mutants in S. cerevisiae [89] and humans [90].”
BackgroundSirtuins as modulators of infection outcomes in the battle of host-pathogen dynamics
Hajra, D., & Chakravortty, D. (2025) · Physics of Life Reviews · doi:10.1016/j.plrev.2025.03.020 · Cited by 4
Effect of SIRT1 on Apoptosis of Bovine Preadipocytes*
Liu, X., Song, E., Liu, G., Gong-Ying, W. U., Tan, X., Liu, Z., & Wan, F. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00583 · Cited by 3
High-level bacterial expression and purification of human SirT2 protein for NMR studies
Sun, C. C., Song, D., Marcotte, P. A., Richardson, P. L., & Hajduk, P. J. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2005.12.006 · Cited by 3
SIRT1 in Metabolic Health and Disease
Boutant, M., & Cantó, C. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_4 · Cited by 4
Nutritional Influences on Epigenetics, Aging and Disease
Meiliana, A., Dewi, N. M., & Wijaya, A. (2019) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v11i1.780 · Cited by 4
“Sirtuins change NAD+ to nicotinamide, which at higher concentrations can non-competitively bind and thereby feedback-inhibit the sirtuin activity.(112,113) The other by-product of the sirtuin deacetylase reaction, O-acetyl-adenosine diphosphate”
BackgroundDietschreit, J. C. B., von der Esch, B., & Ochsenfeld, C. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp05007a · Cited by 3
Longitudinal study of seafood and fish oil supplement intake and risk of persistent tinnitus
Curhan, S. G., Zeleznik, O. A., & Curhan, G. C. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.09.028 · Cited by 5
Goorden, S. M. I., van Haaften–Visser, D. Y., Trętowicz, M. M., Bonte, R., Bogaerts, E., Jamal, Y., Vrieswijk, S., Huijser, E., Bökenkamp, R., van der Palen, R. L. F., et al. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109194 · Cited by 4
Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity
Hwang, E. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813939-4.00029-2 · Cited by 5
Henricksen, L. A., & Federoff, H. J. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6s608 · Cited by 3
“Nicotinamide actually inhibits SIR2 [3] so its removal and conversion back to NAD + are potentially important for maintenance of SIR2 function.”
A Tribute to Arthur Kornberg 1918–2007
Fuller, R. S. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0108-2 · Cited by 3
Assessment of HDACi-Induced Acetylation of Nonhistone Proteins by Mass Spectrometry
Wieczorek, M., Gührs, K., & Heinzel, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6527-4_23 · Cited by 3
Nicotinamide adenine dinucleotide+ metabolism biomarkers in malignant gliomas
Lucena-Cacace, A., Jiménez-García, M. P., & Verdugo-Sivianes, E. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.196912 · Cited by 7
Epigenetic Mechanisms of Sirtuins in Dermatology
Lo, A., Serravallo, M., & Jagdeo, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00008-4 · Cited by 5
Kumar, A., & Dvir‐Ginzberg, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823928-5.00028-1 · Cited by 3
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2015) · Inside the Cell · doi:10.1002/icl3.1036 · Cited by 3
Structure of the Sir2 Family of NAD+-Dependent Histone/Protein Deacetylases
Zhao, K., & Marmorstein, R. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:203 · Cited by 3
“The possibility of generating Sir2-activating compounds has also generated considerable interest ( 6 ).”
BackgroundInfluentialLevin, M., & Adams, D. S. (2016) · Institute of Physics eBooks · doi:10.1088/978-0-7503-1326-1ch5 · Cited by 3
Non-canonical chromatin-based functions for the threonine metabolic pathway
Chik, J., Su, X. B., Klepin, S., Raygoza, J., & Pillus, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-72394-z · Cited by 3
Cellular senescence as a systems-level driver of cardiovascular ageing
Wang, M.-M., Liu, T., Xu, C.-Q., Zhong, Y.-L., Liang, Z.-Q., Li, J., Cao, Y., & Chen, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103175 · Cited by 4
The Impact of Ramadan Fasting on SIRT1 mRNA Expression in Peripheral Blood Mononuclear Cells
Molahoseini, M. H., Gorjipour, K., & Yeganeh, F. (2016) · Research in Molecular Medicine · doi:10.18869/acadpub.rmm.4.4.51 · Cited by 2
Dynamic global acetylation remodeling during the yeast heat shock response
Hardman-Kavanaugh, R. E., Storey, A. J., Stuecker, T. N., Hood, S. E., Barrett‐Wilt, G. A., Krishnamurthi, V. R., Wang, Y., Byrum, S. D., Mackintosh, S. G., Edmondson, R. D., et al. (2026) · Genome biology · doi:10.1186/s13059-026-04194-9 · Cited by 2
“Nicotinamide (an inhibitor of sirtuins [32, 33]) levels mildly spiked at 5 min before decreasing by ~ 40% at 30 min (Fig.”
Evaluation of the Role of PnuC Gene in Enhancing Nicotinamide Mononucleotide Synthesis
Vo, G. T. T., Nguyen, K. K. H., & Kim, B. S. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2713 · Cited by 2
Nicotinamide ameliorates podocyte injury and albuminuria in adriamycin-induced nephropathy
Takahashi, K., Sato, E., Yamakoshi, S., Ogane, M., Sekimoto, A., Ishikawa, T., Kisu, K., Oe, Y., Okamoto, K., Miyazaki, M., et al. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00297.2024 · Cited by 3
Kalita, A. I., Letai, C. T., Enriquez-Hesles, E., Power, L. N., Mishra, S., Saha, S., Dinda, M., Wang, D., Singh, P., & Smith, J. S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111158 · Cited by 2
“NAM supplementation at high concentrations therefore phenocopies the effect of deleting the SIR2 gene, reducing RLS and extending CLS (9, 11).”
Update to Medicinal Chemistry of Nicotinamide in the Treatment of Ischemia and Reperfusion
Yang, J., Klaidman, K., & Adams, J. D., Jr. (2004) · Medicinal Chemistry Reviews - Online · doi:10.2174/1567203043480403 · Cited by 2
“Nicotinamide, possibly, is a physiologically relevant regulator of Sir2 enzymes [28].”
BackgroundSirtuins as Metabolic Modulators of Muscle Plasticity
Menzies, K. J., Zaldivar‐Jolissaint, J. F., & Auwerx, J. H. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_9 · Cited by 2
SIRT1720 promotes survival of corneal epithelial cells via the P53 pathway
Jalil, H. A., Al-Sudani, B. T., & Jasim, G. A. (2022) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2022.906 · Cited by 3
Heywood, H. K., Thorpe, S. D., Jeropoulos, R. M., Caton, P., & Lee, D. A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.971932 · Cited by 2
“in the absence of NAM, illustrated by the premature deviation from the linear initial proliferation rate (Figures 3D,E) and consistent with the known role of SIRT1 antagonising senescence (Bitterman et al., 2002; Li and Tollefsbol, 2011).”
BackgroundMethodThe effect of glucose on transcription at CpxR and OmpR-regulated promoters
Cosgrove, A. C. (2012) · Loyola eCommons (Loyola University of Chicago) · Cited by 2
The Class III Protein Deacetylases
Schwer, B., North, B. J., Ahuja, N., Marshall, B. L., & Verdin, E. M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:237 · Cited by 2
Hajra, D., Rajmani, R. S., Chaudhary, A. D., Gupta, S. K., & Chakravortty, D. (2024) · eLife · doi:10.7554/elife.93125.3 · Cited by 2
Ayano, T., Yokosawa, T., & Oki, M. (2024) · Genes to Cells · doi:10.1111/gtc.13094 · Cited by 1
“Nicotinamide (NAM), an HDAC inhibitor of Sir2, was added to the WT strain to confirm its effect at the single-cell level (Figure 5c and Movie EV8) (Avalos et al., 2005; Bitterman et al., 2002; Imai et al., 2000).”
MethodAyano, T., & Oki, M. (2024) · Genes & Genetic Systems · doi:10.1266/ggs.23-00284 · Cited by 1
Liu, S., Ye, Z., Song, J., Liu, Y., & Li, S. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04479-4 · Cited by 1
“…and the inhibitory concentrations (5 mM and 25 mM) were in the same range as the reported inhibitory intervals of the fungus, sodium butyrate 1–10 mM (Nguyen et al. 2011; Zheng et al. 2023) and nicotinamide 5–50 mM (Bitterman et al. 2002 ; Garnaud et al. 2016; Xing et al. 2019), Consistently.”
Xie, Y., Zhou, C., Guo, Q.-L., Guo, Y., Guo, J., Chen, L., Liu, X., Zeng, Y., Liang, Q., Wu, T., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu0955 · Cited by 4
“SIRT1 is a classical deacetylase protein, and NIA can directly inhibit SIRT1 activity and its deacetylation function in vitro ( 50 ).”
Hwang, E. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18722-3.00011-6 · Cited by 1
Li, G., Zhao, Y., Liu, R., Du, W., & Zhang, Y. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10991-9 · Cited by 1
“Nicotinamide (NAM), an inhibitor of SIRT1, delays cell aging by blocking the hydrolysis of nicotinamide adenine dinucleotide (NAD+) and has been reported to be utilized to expand HSPCs [16].”
Ma, Y., Chen, J., Song, R., & Yu, X. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01503-7 · Cited by 2
“This vastly expands the repertoire of sirtuin-mediated secondary signaling molecules, while NAM serves as a potent endogenous inhibitor providing negative feedback regulation (Bitterman et al. 2002).”
A Function-Centric Framework for Mitochondrial Quality Control
Ozcan, F., Vujovic, F., & Farahani, R. H. (2026) · Biomolecules · doi:10.3390/biom16081116 · Cited by 1
“Sirt1 consumes NAD + and generates nicotinamide (NAM), which feeds back as a product inhibitor [350], so continuous Sirt1 activity requires efficient reconversion of NAM into NAD + via the salvage pathway.”
Stilger, K. L. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/303 · Cited by 1
The Enzymology of SIR2 Proteins
Borra, M. T., & Denu, J. M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:219 · Cited by 1
“It was first postulated that nicotinamide binds to an allosteric site and consequently inhibits Sir2 activity ( 41 ).”
BackgroundDNA Methylation: A Possible Target for Current and Future Studies on Cancer?
Sajadian, S. O., & Nussler, A. K. (2015) · Epigenetic Diagnosis & Therapy · doi:10.2174/2214083201666150220233430 · Cited by 3
NAD‐Dependent Deacetylases as Therapeutic Targets
Li, H., Simon, J. A., & Bedalov, A. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627073.ch10 · Cited by 1
The Role of Epigenetic Modifications in Cancer
Powell, M. J., Popov, V. M., Wang, X., McMahon, S. B., Mazo, A., & Pestell, R. G. (2011) · Wiley eBooks · doi:10.1002/9781118005743.ch7 · Cited by 1
Bayram, A., & İğci, M. (2013) · Fırat Tıp Dergisi · Cited by 10
Advances in Sirtuin on The Mechanism of Calorie Restriction on Lifespan*
Liu, B., Chen, W., Liu, X., & Zhou, Z. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00146 · Cited by 1
Oncolytic Viruses and Histone Deacetylase Inhibitors
Patil, V. M., & Gupta, S. P. (2014) · CRC Press eBooks · doi:10.1201/b16780-14 · Cited by 1
Biochemistry and Enzymology of Sirtuins
Yang, Y. J., & Sauve, A. A. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_1 · Cited by 4
Smith, J. T., & Schneider, B. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00029-4 · Cited by 1
Zähringer, S., Rumpf, T., Melesina, J., Lang, A. E., Aktories, K., Sippl, W., Jung, M., & Wagner, G. K. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116875 · Cited by 1
Moreno, D. F., & Açar, M. (2020) · Current Genetics · doi:10.1007/s00294-020-01124-5 · Cited by 1
Biswas, P., & Dam, S. (2020) · Haya The Saudi Journal of Life Sciences · doi:10.36348/sjls.2020.v05i08.002 · Cited by 1
“Increasing cellular concentration of nicotinamide may feedback-inhibit sirtuin activity by non-competitive binding [13, 14].”
BackgroundMiller, G. S. (2010) · Human Biology · Cited by 1
Functional analysis of mitochondrial sirtuins in C. elegans and mammalian cells
Wirth, M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3229 · Cited by 1
Strauß, E. (2003) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2003.19.nf10 · Cited by 1
Models of acetylation and the regulation of longevity: From yeast to humans
Finkel, M., & Cohen, H. Y. (2005) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2005.11.003 · Cited by 1
Self-citationAnderson, R. M., Colman, R. J., & Weindruch, R. H. (2009) · Springer eBooks · doi:10.1007/978-90-481-3465-6_4 · Cited by 2
Self-citationGhosh, H. S. (2007) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Functional Characterisation of Three Human Nicotinamide Mononucleotide Adenylyltransferases
Lau, C. (2008) · NORA - Norwegian Open Research Archives · Cited by 2
Brow, S. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013455 · Cited by 3
“Its own reaction product, nicotinamide (NAM) inhibits SIRT1 in a self-regulatory feedback loop (Bitterman et al 2002).”
BackgroundTHE IMPACT OF INTERVAL INTENSITY IN OVERWEIGHT YOUNG MEN
Boyd, J. C. (2012) · QSpace (Queen's University Library) · Cited by 1
Smith, D. L., & Smith, J. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-3465-6_6 · Cited by 1
“cells such that 5 mM NAM in the growth media completely inhibits Sir2-mediated gene silencing, causing hyper recombination in the rDNA, and shortened RLS [68].”
BackgroundNovel NAD+ metabolomic technologies and their applications to Nicotinamide Riboside interventions
Trammell, S. A. J., Wright, M. E., Piper, R. C., Brenner, C., Slusarski, D. C., & Wilson, M. E. (2016) · doi:10.17077/etd.mk206led · Cited by 1
“According to this view, sirtuin activation would likely be part of the mechanism because Nam is an NAD precursor in most cells (87, 134) but is a sirtuin inhibitor at high doses (141).”
Adipose Triglyceride Lipase Mediated Regulation Of Sirtuin1 And Lipophagy
Sathyanarayan, A. (2016) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
SIRT1 promotes EMT, migration and invasion by regulating mTORC1/4E-BP1 in colorectal cancerPreprint
Liu, P., Chen, X., Qin, S., Zhou, Y., Yu, B., Luo, Y., Xie, Y., Liu, H., Zhong, M., & Kong, X. (2020) · doi:10.21203/rs.2.24358/v1 · Cited by 1
“Meanwhile, recent studies exposed that nicotinamide (NAM), as a product of deacetylation, noncompetitively inhibited SIRT1[40, 41].”
BackgroundConnell, N. J. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210122nc · Cited by 1
Pichová, A., Heeren, G., Laun, P., Breitenbach, M., & Jarolim, S. (2004) · CRC Press eBooks · doi:10.1201/9780203503867.ch2 · Cited by 1
Hajra, D., Rajmani, R. S., Chaudhary, A. D., Gupta, S. K., & Chakravortty, D. (2024) · eLife · doi:10.7554/elife.93125.1 · Cited by 1
Hajra, D., Rajmani, R. S., Chaudhary, A. D., Gupta, S. K., & Chakravortty, D. (2024) · eLife · doi:10.7554/elife.93125.2 · Cited by 1
Preiss-Handler経路によらないNAD^+合成にnicotinamide ribosideは関与している
梅澤, 智., & 新, 真. (2005) · ビタミン · doi:10.20632/vso.79.5-6_297 · Cited by 1
Forst, A. H., & Lüscher, B. (2014) · RWTH Publications (RWTH Aachen)
Egan, B. (2008) · Dublin City University Open Access Institutional Repository (Dublin City University)
NAD^+の新規な前駆体,Nicotinamide ribosideへの期待
新, 真. (2007) · ビタミン · doi:10.20632/vso.81.12_624
The FoxO Transcription Factors and Sirtuins
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch4
Metadata
- Authors
- Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Sinclair, David A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 47
- Pages
- 45099-45107
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2167990179
- Cited by
- 1,002
- References
- 66
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 41 · 2020: 38 · 2019: 39 · 2018: 47 · 2017: 43 · 2016: 43 · 2015: 58 · 2014: 40 · 2013: 58 · 2012: 56
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6554 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG11972-01)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- nicotinamide, Sir2, SIRT1, transcriptional silencing, heterochromatin, replicative lifespan, aging, NAD+ hydrolysis, enzyme inhibition, p53, apoptosis, histone deacetylation
- MeSH terms
- Aging, DNA, Ribosomal, Genes, Fungal, Histone Deacetylases, Humans, Life Expectancy, Luminescent Proteins, Models, Biological, Niacinamide, Recombinant Fusion Proteins, Recombination, Genetic, Saccharomyces cerevisiae, Molecular Structure, Telomere, Gene Silencing, Sirtuins, Silent Information Regulator Proteins, Saccharomyces cerevisiae, Green Fluorescent Proteins, Sirtuin 1, Sirtuin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.